FdaApplication
BLA 021629
Identifiers
- fda_app_no: BLA021629
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi-Aventis U.S. LLC |
| application_type | BLA |
| approval_date | 2004-04-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APIDRA | INSULIN GLULISINE RECOMBINANT | 1,000UNITS/10ML (100UNITS/ML) | Injection |
| APIDRA | INSULIN GLULISINE RECOMBINANT | 300UNITS/3ML (100UNITS/ML) | Injection |
| APIDRA | INSULIN GLULISINE RECOMBINANT | 300UNITS/3ML (100UNITS/ML) | Injection |
3 products